World's Best Scientists 2026 revealed!
Mark D. Eisner

Mark D. Eisner

D-Index & Metrics

Medicine

D-Index
88
Citations
26972
World Ranking
13213
National Ranking
6732

Overview

Mark D. Eisner is affiliated with Genentech in the United States and has contributed to multiple areas within medicine. Their work spans several subfields including cardiology and cardiovascular medicine, oncology, hematology, dermatology, and molecular biology.

Their research topics encompass a range of medical and biological subjects such as:

  • Cardiac electrophysiology and arrhythmias
  • Atrial Fibrillation Management and Outcomes
  • Erythropoietin and Anemia Treatment
  • Cancer and Skin Lesions
  • Muscle Physiology and Disorders
  • Connective Tissue Growth Factor Research
  • Fibromyalgia and Chronic Fatigue Syndrome Research

Frequent publication venues for Mark D. Eisner include:

  • British Journal of Dermatology
  • Journal of Neuromuscular Diseases
  • Circulation Research
  • Journal of Clinical Oncology
  • Therapeutic Advances in Medical Oncology

Key recent publications feature the following works:

  • Pamrevlumab, a Fully Human Monoclonal Antibody Targeting Connective Tissue Growth Factor, for Non-Ambulatory Patients with Duchenne Muscular Dystrophy, 2023, Journal of Neuromuscular Diseases
  • Restoring Atrial T-Tubules Augments Systolic Ca Upon Recovery From Heart Failure, 2024, Circulation Research
  • Efficacy and Safety of Roxadustat for Anemia in Patients Receiving Chemotherapy for Nonmyeloid Malignancies: A Randomized, Open-Label, Active-Controlled Phase III Study, 2024, Journal of Clinical Oncology
  • A novel event-free survival endpoint in locally advanced pancreatic cancer, 2021, Therapeutic Advances in Medical Oncology
  • A rash refractory to treatment, 2020, BMJ

Mark D. Eisner has collaborated frequently with a core group of coauthors including:

  • Ewa Carrier
  • Jessica L. Caldwell
  • Jessica D. Clarke
  • Charlotte Smith
  • Christian Pinali

Best Publications

  • Lebrikizumab Treatment in Adults with Asthma

    Jonathan Corren;Robert F. Lemanske;Nicola A. Hanania;Phillip E. Korenblat

  • An Official American Thoracic Society Public Policy Statement: Novel Risk Factors and the Global Burden of Chronic Obstructive Pulmonary Disease

    Mark D. Eisner;Nicholas Anthonisen;David Coultas;Nino Kuenzli

  • Pulmonary dead-space fraction as a risk factor for death in the acute respiratory distress syndrome.

    Thomas J Nuckton;James A Alonso;Richard H Kallet;Brian M Daniel

  • Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury.

    Polly E. Parsons;Mark D. Eisner;B Taylor Thompson;Michael A. Matthay

  • Pathogenetic and prognostic significance of altered coagulation and fibrinolysis in acute lung injury/acute respiratory distress syndrome

    Mauro Oddo;Marie-Denise Schaller;François Feihl;Vincent Ribordy

  • COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care Program.

    Stephen Sidney;Michael Sorel;Charles P. Quesenberry;Cynthia DeLuise

  • Omalizumab in severe allergic asthma inadequately controlled with standard therapy: a randomized trial.

    Nicola A. Hanania;Oral Alpan;Daniel L. Hamilos;John J. Condemi

  • Bartenders' Respiratory Health After Establishment of Smoke-Free Bars and Taverns

    Mark D. Eisner;Alexander K. Smith;Paul D. Blanc

  • Recent trends in acute lung injury mortality: 1996-2005.

    Sara E. Erickson;Greg S. Martin;J Lucian Davis;Michael A. Matthay

  • Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-controlled trials

    Nicola A Hanania;Phillip Korenblat;Kenneth R Chapman;Kenneth R Chapman;Eric D Bateman

  • The occupational burden of chronic obstructive pulmonary disease

    L Trupin;G Earnest;M San Pedro;J R Balmes

  • Plasma receptor for advanced glycation end products and clinical outcomes in acute lung injury

    C S Calfee;L B Ware;M D Eisner;P E Parsons

  • Efficacy of Low Tidal Volume Ventilation in Patients with Different Clinical Risk Factors for Acute Lung Injury and the Acute Respiratory Distress Syndrome

    Mark D. Eisner;Taylor Thompson;Leonard D. Hudson;John M. Luce

  • Lifetime environmental tobacco smoke exposure and the risk of chronic obstructive pulmonary disease

    Mark D Eisner;John R. Balmes;Patricia P Katz;Laura Trupin

  • Plasma surfactant protein levels and clinical outcomes in patients with acute lung injury

    M D Eisner;P Parsons;M A Matthay;L Ware

  • A Comprehensive Study of the Direct and Indirect Costs of Adult Asthma

    Miriam G. Cisternas;Paul D. Blanc;Irene H. Yen;Patricia P. Katz

  • Significance of Von Willebrand Factor in Septic and Nonseptic Patients with Acute Lung Injury

    Lorraine B. Ware;Mark D. Eisner;B. Taylor Thompson;Polly E. Parsons

  • Influence of anxiety on health outcomes in COPD

    Mark D Eisner;Paul D Blanc;Edward H Yelin;Patricia P Katz

  • Trauma-associated lung injury differs clinically and biologically from acute lung injury due to other clinical disorders.

    Carolyn S. Calfee;Mark D. Eisner;Lorraine B. Ware;B Taylor Thompson

  • Lifetime environmental tobacco smoke exposure and the risk of chronic obstructive pulmonary disease: Environmental Health: A Global Access Science Source 2005;4:7. doi:10.1186/1476-069X-4-7 2005;12:4(1):7.

    M.D. Eisner;J. Balmes;P.P. Katz;L. Trupin

Frequent Co-Authors

Paul D. Blanc
Paul D. Blanc University of California, San Francisco
Edward H. Yelin
Edward H. Yelin University of California, San Francisco
Patricia P. Katz
Patricia P. Katz University of California, San Francisco
Carlos Iribarren
Carlos Iribarren Kaiser Permanente
Michael A. Matthay
Michael A. Matthay University of California, San Francisco
John R. Balmes
John R. Balmes University of California, Berkeley
Lorraine B. Ware
Lorraine B. Ware Vanderbilt University Medical Center
B. Taylor Thompson
B. Taylor Thompson Harvard University
Neal L. Benowitz
Neal L. Benowitz University of California, San Francisco
Carolyn S. Calfee
Carolyn S. Calfee University of California, San Francisco

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering a career in Medicine but want flexible study options, online healthcare degrees can open exciting new pathways. Online nursing programs have become increasingly popular, allowing students to balance coursework with personal and professional commitments. These programs cover foundational knowledge and clinical skills vital for a career in healthcare.

For registered nurses seeking career advancement, the cheapest rn to bsn online programs offer a cost-effective way to earn a bachelor’s degree and access higher-level opportunities. Similarly, individuals aiming for leadership or research roles may explore phd in nursing online programs, which focus on advanced practice, research, and teaching.

Those with a non-nursing background who want to transition into the nursing profession may consider msn direct entry programs online. These programs accelerate entry into nursing careers by combining core skills and clinical training, making them an appealing choice for career changers.

With a variety of affordable, flexible online programs, aspiring healthcare professionals have more options than ever to launch or advance their medical careers.

Best Scientists Citing Mark D. Eisner

Trending Scientists